KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Cash & Equivalents (2016 - 2026)

Historic Cash & Equivalents for Silicon Laboratories (SLAB) over the last 18 years, with Q1 2026 value amounting to $364.2 million.

  • Silicon Laboratories' Cash & Equivalents rose 2933.7% to $364.2 million in Q1 2026 from the same period last year, while for Jan 2026 it was $364.2 million, marking a year-over-year increase of 2933.7%. This contributed to the annual value of $364.2 million for FY2026, which is 2933.7% up from last year.
  • Per Silicon Laboratories' latest filing, its Cash & Equivalents stood at $364.2 million for Q1 2026, which was up 2933.7% from $341.4 million recorded in Q4 2025.
  • Silicon Laboratories' Cash & Equivalents' 5-year high stood at $1.1 billion during Q1 2022, with a 5-year trough of $159.9 million in Q3 2023.
  • Over the past 5 years, Silicon Laboratories' median Cash & Equivalents value was $324.9 million (recorded in 2025), while the average stood at $413.5 million.
  • As far as peak fluctuations go, Silicon Laboratories' Cash & Equivalents skyrocketed by 43010.21% in 2022, and later crashed by 7326.98% in 2024.
  • Quarter analysis of 5 years shows Silicon Laboratories' Cash & Equivalents stood at $499.9 million in 2022, then crashed by 54.49% to $227.5 million in 2023, then increased by 23.78% to $281.6 million in 2024, then increased by 21.23% to $341.4 million in 2025, then grew by 6.68% to $364.2 million in 2026.
  • Its Cash & Equivalents stands at $364.2 million for Q1 2026, versus $341.4 million for Q4 2025 and $314.5 million for Q3 2025.